These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 25957705)
1. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract. Zur M; Cohen N; Agbaria R; Dahan A Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705 [TBL] [Abstract][Full Text] [Related]
3. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification. Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288 [TBL] [Abstract][Full Text] [Related]
4. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation. Zur M; Hanson AS; Dahan A Eur J Pharm Sci; 2014 Sep; 61():11-7. PubMed ID: 24262076 [TBL] [Abstract][Full Text] [Related]
5. The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol. Zur M; Gasparini M; Wolk O; Amidon GL; Dahan A Mol Pharm; 2014 May; 11(5):1707-14. PubMed ID: 24735251 [TBL] [Abstract][Full Text] [Related]
6. BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide. Markovic M; Zur M; Ragatsky I; Cvijić S; Dahan A Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33276565 [TBL] [Abstract][Full Text] [Related]
7. Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development. Markovic M; Zur M; Fine-Shamir N; Haimov E; González-Álvarez I; Dahan A Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32214015 [TBL] [Abstract][Full Text] [Related]
8. Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine. Fairstein M; Swissa R; Dahan A AAPS J; 2013 Apr; 15(2):589-97. PubMed ID: 23440549 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification. Incecayir T; Tsume Y; Amidon GL Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720 [TBL] [Abstract][Full Text] [Related]
10. Regional intestinal drug permeation: biopharmaceutics and drug development. Lennernäs H Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845 [TBL] [Abstract][Full Text] [Related]
11. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Dahan A; Amidon GL Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230 [TBL] [Abstract][Full Text] [Related]
12. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation. Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569 [TBL] [Abstract][Full Text] [Related]
13. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests. Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Defang O; Shufang N; Wei L; Hong G; Hui L; Weisan P Drug Dev Ind Pharm; 2005 Aug; 31(7):677-85. PubMed ID: 16207615 [TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of mucoadhesive beads of glipizide as a controlled release drug delivery system. Bera K; Khanam J; Mohanraj KP; Mazumder B J Microencapsul; 2014; 31(3):220-9. PubMed ID: 24047213 [TBL] [Abstract][Full Text] [Related]
16. Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies. Kushare SS; Gattani SG J Pharm Pharmacol; 2013 Jan; 65(1):79-93. PubMed ID: 23215691 [TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutics classification and intestinal absorption study of apigenin. Zhang J; Liu D; Huang Y; Gao Y; Qian S Int J Pharm; 2012 Oct; 436(1-2):311-7. PubMed ID: 22796171 [TBL] [Abstract][Full Text] [Related]
18. Biopharmaceutic Risk Assessment of Brand and Generic Lamotrigine Tablets. Vaithianathan S; Raman S; Jiang W; Ting TY; Kane MA; Polli JE Mol Pharm; 2015 Jul; 12(7):2436-43. PubMed ID: 26001027 [TBL] [Abstract][Full Text] [Related]
19. Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet). Li H; Cao X; Liu Y; Liu T; Wang M; Ren X; Dou Z J Ethnopharmacol; 2019 Nov; 244():112148. PubMed ID: 31400507 [TBL] [Abstract][Full Text] [Related]
20. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]